- Report
- July 2025
- 175 Pages
Global
From €3988EUR$4,490USD£3,485GBP
- Report
- September 2025
- 250 Pages
Global
From €3988EUR$4,490USD£3,485GBP
- Report
- November 2025
- 132 Pages
Global
From €844EUR$950USD£737GBP
The Pediatric Genetic Testing market is a subset of the larger Genomics market, which focuses on the study of genetic material. Pediatric Genetic Testing is used to identify genetic disorders in children, and can be used to diagnose, treat, and manage a variety of conditions. It can also be used to identify inherited conditions, such as cystic fibrosis, and to detect chromosomal abnormalities, such as Down syndrome. Pediatric Genetic Testing can also be used to identify genetic mutations that may be associated with certain diseases, such as cancer.
Pediatric Genetic Testing is typically performed through a variety of methods, including blood tests, saliva tests, and tissue biopsies. The results of these tests can be used to inform treatment decisions and to provide parents with information about their child's health.
Companies in the Pediatric Genetic Testing market include Illumina, Thermo Fisher Scientific, Myriad Genetics, and Invitae. Show Less Read more